Search Results - "DRACHMAN, D"

Refine Results
  1. 1

    Statins and the risk of dementia by Jick, H, Zornberg, GL, Jick, SS, Seshadri, S, Drachman, DA

    Published in The Lancet (British edition) (11-11-2000)
    “…Dementia affects an estimated 10% of the population older than 65 years. Because vascular and lipid-related mechanisms are thought to have a role in the…”
    Get full text
    Journal Article
  2. 2

    Mycophenolate mofetil : A safe and promising immunosuppressant in neuromuscular diseases by CHAUDHRY, V, CORNBLATH, D. R, GRIFFIN, J. W, O'BRIEN, R, DRACHMAN, D. B

    Published in Neurology (09-01-2001)
    “…The authors report the use mycophenolate mofetil (MM) in the treatment of neuromuscular diseases. Thirty-eight patients (32 with MG, three with inflammatory…”
    Get full text
    Journal Article
  3. 3

    Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis by Selim, M, Drachman, D A

    “…Acquired cerebellar ataxia has been described with hypothyroidism, and is typically reversible by thyroid hormone replacement therapy. The cerebellar…”
    Get full text
    Journal Article
  4. 4

    Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia by Watts, GDJ, Thomasova, D, Ramdeen, SK, Fulchiero, EC, Mehta, SG, Drachman, DA, Weihl, CC, Jamrozik, Z, Kwiecinski, H, Kaminska, A, Kimonis, VE

    Published in Clinical genetics (01-11-2007)
    “…Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia (IBMPFD, OMIM 167320) has recently been attributed to eight missense…”
    Get full text
    Journal Article
  5. 5

    Myasthenia Gravis by Drachman, Daniel B

    Published in The New England journal of medicine (23-06-1994)
    “…Twenty years ago, the discovery of a deficit of acetylcholine receptors at the neuromuscular junctions of patients with myasthenia gravis 1 and the development…”
    Get full text
    Journal Article
  6. 6

    Head drop and camptocormia by Umapathi, T, Chaudhry, V, Cornblath, D, Drachman, D, Griffin, J, Kuncl, R

    “…Table 1 Neuromuscular causes for head ptosis Site of pathology Disorders Motor neuron Amyotrophic lateral sclerosis 1, 2 Postpolio syndrome 3 Peripheral nerve…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo : The Guided Missile strategy by Sun, W, Adams, R.N, Miagkov, A, Lu, Y, Juon, H.-S, Drachman, D.B

    Published in Journal of neuroimmunology (15-10-2012)
    “…Abstract Current immunotherapy of myasthenia gravis (MG) is often effective, but entails risks of infection and neoplasia. The “Guided Missile” strategy…”
    Get full text
    Journal Article
  9. 9

    Granzyme B: Evidence for a role in the origin of myasthenia gravis by Casciola-Rosen, L, Miagkov, A, Nagaraju, K, Askin, F, Jacobson, L, Rosen, A, Drachman, D.B

    Published in Journal of neuroimmunology (15-09-2008)
    “…Abstract Purpose of research Although the pathogenesis of myasthenia gravis (MG) as an antibody mediated disorder of acetylcholine receptors (AChRs) at…”
    Get full text
    Journal Article
  10. 10

    Expression of heat shock proteins in Alzheimer's disease by HAMOS, J. E, OBLAS, B, PULASKI-SALO, D, WELCH, W. J, BOLE, D. G, DRACHMAN, D. A

    Published in Neurology (01-03-1991)
    “…In an investigation of heat shock proteins (HSPs) in the brains of Alzheimer's disease (AD) patients and cognitively intact control subjects, we found that 2…”
    Get full text
    Journal Article
  11. 11

    Familial Alzheimer's disease: Site of mutation influences clinical phenotype by Lippa, C. F., Swearer, J. M., Kane, K. J., Nochlin, D., Bird, T. D., Ghetti, B., Nee, L. E., St. George-Hyslop, P., Pollen, D. A., Drachman, D. A.

    Published in Annals of neurology (01-09-2000)
    “…Alzheimer's disease (AD) is caused by multiple genetic and/or environmental etiologies. Because differences in the genetically determined pathogenesis may…”
    Get full text
    Journal Article
  12. 12

    Cerebral Thromboembolism: Value of Susceptibility-Weighted Imaging in the Initial Diagnosis of Acute Infarction by Mamlouk, M.D., Tsai, F.Y., Drachman, D., Stradling, D., Hasso, A.N.

    Published in The neuroradiology journal (01-02-2012)
    “…Susceptibility-weighted imaging (SWI) is commonly used to diagnose cerebral hemorrhage, calcification, and other T2* lesions. Its role in the detection of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months by Drachman, Douglas E, Edelman, Elazer R, Seifert, Philip, Groothuis, Adam R, Bornstein, Danielle A, Kamath, Kalpana R, Palasis, Maria, Yang, Dachuan, Nott, Sepideh H, Rogers, Campbell

    “…OBJECTIVES The purpose of this study was to determine long-term effects of stent-based paclitaxel delivery on amount, rate and composition of neointimal…”
    Get full text
    Journal Article
  15. 15

    Aging and the brain: a new frontier by Drachman, D A

    Published in Annals of neurology (01-12-1997)
    “…With aging, both "normal" senescent age-related changes (ARCs) and late-onset diseases affect the brain, producing declines in performance. The brain as a…”
    Get more information
    Journal Article
  16. 16

    Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis by Rothstein, J D, Tsai, G, Kuncl, R W, Clawson, L, Cornblath, D R, Drachman, D B, Pestronk, A, Stauch, B L, Coyle, J T

    Published in Annals of neurology (01-07-1990)
    “…Recently, the excitatory amino acid neurotransmitter glutamate was implicated in the pathogenesis of a variety of chronic degenerative neurological diseases in…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Familial and sporadic Alzheimer's disease : Neuropathology cannot exclude a final common pathway by LIPPA, C. F, SAUNDERS, A. M, BERGERON, C, CRAIN, B, BENSON, M. D, FARLOW, M, HYMAN, B. T, GEORGE-HYSLOP, P. S, ROSES, A. D, POLLEN, D. A, SMITH, T. W, SWEARER, J. M, DRACHMAN, D. A, GHETTI, B, NEE, L, PULASKI-SALO, D, DICKSON, D, ROBITAILLE, Y

    Published in Neurology (01-02-1996)
    “…Whether all etiologic forms of Alzheimer's disease (AD) share a final common pathway is a major issue. We determined the severity and regional distribution of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis by Drachman, Daniel B., Rothstein, Jeffrey D.

    Published in Annals of neurology (01-11-2000)
    “…The pathogenesis of motor neuron loss in amyotrophic lateral sclerosis (ALS) is thought to involve both glutamate‐mediated excitotoxicity and oxidative damage…”
    Get full text
    Journal Article